Theriva Biologics shares owned by Barclays
Quarter-by-quarter ownership of Theriva Biologics shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Theriva Biologics
Tip: Access up to 7 years of quarterly data
All positions including Theriva Biologics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theriva Biologics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $999 | 495 | 2.02 |